Hematologic Malignancies

SH 04 - Science Highlights 04 - Hematologic Cancers

9/17/2019
8:30 AM - 9:00 AM
Location: Room W181

Session Type: Science Highlights
0.50 AMA PRA Category 1 Credits™
0.50 CAMPEP Credits

This session will review the most impactful abstracts in the Hematologic track:
* PET-Guided Treatment of Early-Stage Favorable Hodgkin Lymphoma: Final Results of the International, Randomized Phase 3 Trial HD16 by the GHSG
* Consolidating involved field radiotherapy prevents early and local recurrences in early stage Hodgkin Lymphoma
* Long-Term Outcomes for Patients With Limited Stage Follicular Lymphoma: An Update of a Population-based Study
* Induction radiation prior to commercial chimeric antigen receptor T-cell therapy for relapsed/refractory non-Hodgkin lymphoma
* Patterns of Failure Following Chimeric Antigen Receptor T-cell (CAR-T) Therapy

Presentations:


Assets

SH 04 - Science Highlights 04 - Hematologic Cancers



Attendees who have favorited this

Please enter your access key

The asset you are trying to access is locked. Please enter your access key to unlock.

Send Email for SH 04 - Science Highlights 04 - Hematologic Cancers